Quality evaluation in haemodialysis treatment through benchmarking : a medical and economical outlook

Détails

Ressource 1Télécharger: BIB_D6B959F06966.P001.pdf (479.41 [Ko])
Etat: Public
Version: Après imprimatur
ID Serval
serval:BIB_D6B959F06966
Type
Mémoire
Collection
Publications
Institution
Titre
Quality evaluation in haemodialysis treatment through benchmarking : a medical and economical outlook
Auteur(s)
Spieldenner Jörg
Directeur(s)
Domenighetti Gianfranco
Editeur
IEMS (Institute of Health Economics and Management)
Détails de l'institution
Université de Lausanne, Faculté des hautes études commerciales
Adresse
Lausanne
Statut éditorial
Acceptée
Date de publication
2006
Genre
Mémoire / Institute of Health Economics and Management ; no 89
Langue
anglais
Nombre de pages
28
Notes
DESS en économie et management de la santé - Master in Health Economics and Management (MHEM) Mention de responsabiblité : / Jörg Spieldenner ; [dir. de mémoire: Gianfranco Domenighetti] SAPHIRID:59401
Résumé
Most stakeholders in the health field want to minimize the burden of illness and have patients maintain their ability to work and enjoy an active, independent life (functional health status), receive the right care (appropriateness) at the right time (access) in a satisfying and efficient manner; and this with available resources avoiding unnecessary costs. Growing evidence, however, suggests that the daily practice of care does not correspond to the standards that the medical profession itself puts forward. To improve care and to realise potential medical and economical benefits, policymakers are looking for methods to measure and benchmark the performance of health care systems. [...]
This debate applies equally to the treatment of end stage renal disease (ESRD) that requires rend replacement therapy. This paper will only analyse dialysis as it is the major renal replacement therapy in Switzerland. [...]
But why is the question of quality in dialysis treatment so important? Firstly, there are legal obligations which are set out in article 43 and 58 of the federal law on health insurance to which the different parties in health care are bound to produce the best quality possible at the lowest costs possible. There are remaining questions about the demand for this type of treatment, the economic impact and the feasibility of implementation of quality control measures. [...] [Author, p. 3]
Mots-clé
Renal Dialysis , Benchmarking
Création de la notice
14/03/2008 10:12
Dernière modification de la notice
20/08/2019 15:56
Données d'usage